Man har i fase II- undersøgelser fundet en klar korrelation mellem dabigatran- koncentrationen i plasma og graden af antikoagulerende effekt.
There is a clear correlation between plasma dabigatran concentration and degree of anticoagulant effect based on phase II studies.